Categories
Health

Novel JAK1 Inhibitor Reduced Treatment Failures in Active Noninfectious Uveitis

Source link : https://www.newshealth.biz/health-news/novel-jak1-inhibitor-reduced-treatment-failures-in-active-noninfectious-uveitis/

An investigational Janus kinase 1 (JAK1) preferential inhibitor reduced the risk of treatment failure among patients with active noninfectious uveitis, the phase II randomized HUMBOLDT trial showed. Though the trial was stopped early, 37.5% of patients with active noninfectious intermediate uveitis, posterior uveitis, or panuveitis who received filgotinib experienced treatment failure by week 24 compared […]

Author : News Health

Publish date : 2024-07-19 17:49:39

Copyright for syndicated content belongs to the linked Source.

.. . . . . . . . . . . . . . . . . . . . . . . . . .... . . * . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . + + + + + + + + + + + + + + + + + + + + - - - - - - - - - - - - - - - - - - - - . . . . .